Magnesium, inflammation, and obesity in chronic disease

Nutrition Reviews

Volumn 68, Issue 6, 2010, Pages 333-340

  Nielsen, Forrest H ^a  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Chronic disease; Inflammation; Magnesium; Obesity; Oxidative stress

Indexed keywords

ADIPONECTIN; ASCORBIC ACID; C REACTIVE PROTEIN; CATALASE; COLLAGEN; ELASTIN; ESTROGEN; FRUCTOSE; GLUTATHIONE TRANSFERASE; INTERLEUKIN 6; LEPTIN; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OMEGA 3 FATTY ACID; RETINOL; SUBSTANCE P ANTAGONIST; SUCROSE; SUPEROXIDE DISMUTASE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; TUMOR NECROSIS FACTOR ALPHA; UBIDECARENONE; ZINC;

ATHEROSCLEROSIS; BLUEBERRY; BODY MASS; CALCIUM INTAKE; CARDIOVASCULAR RISK; CHERRY; CHRONIC INFLAMMATION; COLLAGEN SYNTHESIS; CYTOKINE PRODUCTION; DIABETES MELLITUS; DIETARY INTAKE; GRAPE; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; LIPID PEROXIDATION; MAGNESIUM DEFICIENCY; MYOCARDITIS; NEOPLASM; NONHUMAN; OBESITY; OSTEOPOROSIS; OXIDATIVE STRESS; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; SUGAR INTAKE; TEA; ANIMAL; CHRONIC DISEASE; INFLAMMATION; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALIA;

ANIMALS; CHRONIC DISEASE; HUMANS; INFLAMMATION; MAGNESIUM; MAGNESIUM DEFICIENCY; NUTRITIONAL STATUS; OBESITY;

EID: 77956640666     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2010.00293.x     Document Type: Review

References (88)

1. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus,Magnesium, Vitamin D, and Fluoride. Washington DC: National Academy Press; 1997:190-249.
2. Moshfegh A, Goldman J, Ahuja J, Rodes D, LaComb R. What We Eat in America, NHANES 2005-2006: Usual Nutrient Intakes from Food and Water Compared to 1997 Dietary Reference Intakes for Vitamin D, Calcium, Phosphorus, and Magnesium. US Department of Agriculture, Agricultural Research Service; 2009. Available at: Http://www.ars. usda.gov/ba/bhnrc/fsrg. Accessed November 2009.
3. Food and Agriculture Organization/World Health Organization. Vitamin and Mineral Requirements in Human Nutrition, 2nd ed. Geneva: Food and Agriculture Organization/World Health Organization; 2004:217-228.
4. Ma J, Folsom AR, Melnick SL, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol. 1995;48:927-940.
5. Abbott RD, Ando F, Masaki KH, et al. Dietary magnesium intake and the future risk of coronary heart disease (The Honolulu Heart Program). Am J Cardiol. 2003;92:665-669.
6. Touyz RM. Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med. 2003;24:107-136.
7. Rude RK, Singer FR, Gruber HE. Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr. 2009;28:131-141.
8. Barbagallo M, Dominguez LJ, Galioto A, et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med. 2003;24:39-52.
9. Dai Q, Shrubsole MJ, Ness RM, et al. The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk. Am J Clin Nutr. 2007;86:743-751.
10. Leone N, Courbon D, Ducimetiere P, Zureik M. Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiology. 2006;17:308-314.
11. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-867.
12. Libby P. Inflammatory mechanisms: The molecular basis of inflammation and disease. Nutr Rev. 2007;65(Suppl):S140-S146.
13. Kruse HD, Orent ER, McCollum EV. Studies on magnesium deficiency in animals. I. Symptomatology resulting from magnesium deprivation. J Biol Chem. 1932;96:519-539.
14. Mazur A, Maier JAM, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: Potential physiopathological implications. Arch Biochem Biophys. 2007;458:48-56.
15. Vormann J, Günther T, Höllriegl V, Schümann K. Pathobiochemical effects of graded magnesium deficiency in rats. Z Ernährungswiss. 1998;37(Suppl 1):92-97.
16. Kramer JH, Mak IT, Phillips TM, Weglicki WB. Dietary magnesium intake influences circulating pro-inflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress. Exp Biol Med. 2003;228:665-673.
17. Hegsted DM, Vitale JJ, McGrath H. The effect of low temperature and dietary calcium upon magnesium requirement. J Nutr. 1956;58:175-188.
18. Chaudhary DP, Boparai RK, Bansal DD. Implications of oxidative stress in high sucrose low magnesium diet fed rats. Eur J Nutr. 2007;46:383-390.
19. Busserolles J, Rock E, Gueux E, Mazur A, Grolier P, Rayssiguier Y. Short term consumption of high sucrose diet has a pro-oxidant effect in rats. Br J Nutr. 2002;87:337-342.
20. Busserolles J, Gueux E, Rock E, Mazur A, Rayssiguier Y. High fructose feeding of magnesium deficient rats is associated with increased plasma triglyceride concentration and increased oxidative stress. Magnes Res. 2003;16:7-12.
21. Rayssiguier Y, Gueux E, Nowacki W, Rock E, Mazur A. High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation. Magnes Res. 2006;19: 237-243.
22. Adrian M, Chanut E, Laurant P, Gaume V, Berthelot A. A longterm moderate magnesium-deficient diet aggravates cardio-vascular risks associated with aging and increases mortality in rats. J Hypertens. 2008;26:44-52.
23. Mak IT, Kramer JH, Weglicki WB. Suppression of neutrophil and endothelial activation by substance P receptor blockade in the Mg-deficient rat. Magnes Res. 2003;16:91-97.
24. Atrakchi AH, Bloom S, Dickens BF, Mak IT,WeglickiWB. Hypomagnesemia and isoproterenol cardiomyopathies: Protection by Probucol. J Cardiovasc Pathol. 1992;1:155-160.
25. Freedman AM, Atrakchi AH, Cassidy MM, Weglicki WB. Magnesium deficiency-induced cardiomyopathy: Protection by vitamin E. Biochem Biophys Res Comm. 1990;170:1102-1106.
26. Freedman AM, Cassidy MM, Weglicki WB. Propranolol reduces cardiomyopathic injury induced by magnesium deficiency. Magnes Trace Elem. 1992;10:348-354.
27. Weglicki WB, Freedman AM, Bloom S, et al. Antioxidants and the cardiomyopathy of Mg-deficiency. Am J Cardiovasc Pathol. 1992;4:210-215.
28. Bussière F, Gueux E, Rock E, Mazur A, Rayssiguier Y. Female rats are less susceptible to inflammation induced by magnesium deficiency than males: The influence of estrogen. In: Rayssiguier Y, Mazur A, Durlach J, eds. Advances in Magnesium Research: Nutrition and Health. Eastleigh: John Libbey; 2001:313-314.
29. Rude RK, Wei L, Norton HJ, Lu SS, Dempster DW, Gruber HE. TNFa receptor knockout in mice reduces adverse effects of magnesium deficiency in bone. Growth Factors. 2009;27: 370-376.
30. Ridker PM. Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: Implications for longevity. Nutr Rev. 2007;65(Suppl):S253-S259.
31. King DE, Mainous AG III, Geesey ME, Ellis T. Magnesium intake and serum C-reactive protein levels in children. Magnes Res. 2007;20:32-36.
32. King DE, Mainous AG III, Geesey ME, Woolson RF. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr. 2005;24:166-171.
33. King DE, Mainous AG III, Geesey ME, Egan BM, Rehman S. Magnesium supplement intake and C-reactive protein levels in adults. Nutr Res. 2006;26:193-196.
34. Bo S, Durazzo M, Guidi S, et al. Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am J Clin Nutr. 2006;84:1062-1069.
35. Song Y, Li TY, van Dam RM, Manson JE, Hu FB. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr. 2007;85:1068-1074.
36. Chacko SA, Song Y, Nathan L, et al. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care. 2010;33:304-310.
37. Rodriguez-Morán M, Guerrero-Romero F. Serum magnesium and C-reactive protein levels. Arch Dis Childhood. 2008; 93:676-680.
38. Almoznino-Sarafian D, Berman S, Mor A, et al. Magnesium and C-reactive protein in heart failure: An anti-inflammatory effect of magnesium administration? Eur J Nutr. 2007;46: 230-237.
39. He K, Liu K, Daviglus ML, Morris SJ, et al. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation. 2006;113:1675-1682.
40. Corica F, Corsonello A, Ientile R, et al. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr. 2006;25:210-215.
41. Pradhan A. Obesity, metabolic syndrome, and type 2 diabetes: Inflammatory basis of glucose metabolic disorders. Nutr Rev. 2007;65(Suppl):S152-S156.
42. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: Direct role in obesitylinked insulin resistance. Science. 1993;259:87-91.
43. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821-1830.
44. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-1808.
45. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Speiegelman BM. Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J Clin Invest. 1995;95:2409-2415.
46. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-1119.
47. Canavan B, Salem RO, Schurgin S, et al. Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric restriction. J Clin Endocrinol Metab. 2005;90:5779-5785.
48. Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocytesderived plasma protein, inhibits endothelial NF-kB signaling through a cAMP-dependent pathway. Circulation. 2000;102: 1296-1301.
49. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 1999;12:1971-1977.
50. Aeberli I, Molinari L, Spinas G, Lehmann R, L'Allemand D, Zimmerman MB. Dietary intakes of fat and antioxidant vitamins are predictors of subclinical inflammation in overweight Swiss children. Am J Clin Nutr. 2006;84:748-755.
51. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83.
52. Rodríguez-Morán M, Guerrero-Romero F. Elevated concentrations of TNF-alpha are related to low serum magnesium levels in obese subjects. Magnes Res. 2004;17:189-196.
53. Corica F, Allegra A, Ientile R, Buemi M. Magnesium concentrations in plasma, erythrocytes, and platelets in hypertensive and normotensive obese patients. Am J Hypertens. 1997;10:1311-1313.
54. Lee S, Park HK, Son SP, Lee CW, Kim IJ, Kim HJ. Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in nomomagnesmic nondiabetic overweight Korean adults. Nutr Metab Cardiovasc Dis. 2009;19:781-788.
55. Huerta MG, Roemmich JN, Kington ML, et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care. 2005;28:1175-1181.
56. Corica F, Allegra A, Ientile R, et al. Changes in plasma, erythrocyte, and platelet magnesium levels in normotensive and hypertensive obese subjects during oral glucose tolerance test. Am J Hypertens. 1999;12:128-136.
57. Tejero-Taldo MI, Kramer JH, Mak IT, Komarov AM, Weglicki WB. The nerve-heart connection in the pro-oxidant response to Mg-deficiency. Heart Fail Rev. 2006;11:35-44.
58. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83(Suppl): S1505-S1519.
59. Tejero-Taldo MI, Chmielinska JJ, Gonzalez G, Mak IT, Weglicki WB. N-Methyl-D-aspartate receptor blockade inhib-its cardiac inflammation in the Mg2+-deficient rat. J Pharmacol Exp Therapeut. 2004;311:8-13.
60. Alloui A, Begon S, Chassaing C, et al. Does Mg2+ deficiency induce a long-term sensitization of the central nociceptive pathways? Eur J Pharmacol. 2003;469:65-69.
61. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-295.
62. Durakoglugil M, Irving AJ, Harvey J. Leptin induces a novel form of NMDA receptor-dependent long-term depression. J Neurochem. 2005;95:396-405.
63. Lukaski HC, Nielsen FH. Dietarymagnesium depletion affects metabolic responses during submaximal exercise in postmenopausal women. J Nutr. 2002;132:930-935.
64. Nielsen FH, Milne DB, Gallagher S, Johnson L, Hoverson B. Moderate magnesium deprivation results in calcium retention and altered potassium and phosphorus excretion by postmenopausal women. Magnes Res. 2007;20:19-31.
65. Planells E, Aranda P, Perán F, Llopis J. Changes in calcium and phosphorus absorption and retention during long-term magnesium deficiency in rats. Nutr Res. 1993;13:691-699.
66. Agus MSD, Agus ZS. Cardiovascular actions of magnesium. Crit Care Clin. 2001;17:175-186.
67. Bruton JD, Katz A, Lännergren J, Abbate F, Westerblad H. Regulation of myoplasmic Ca(2+) in genetically obese (ob/ob) mouse single skeletal muscle fibers. Pflugers Arch. 2002;444:692-699.
68. Guermouche B, Yessoufou A, Soulimane N, et al. n-3 fatty acids modulate T-cell calcium signaling in obese macrosomic rats. Obes Res. 2004;12:1744-1753.
69. Nakata M, Maruyama I, Yada T. Leptin potentiates ADPinduced [Ca(2+)] (i) increase via JAK2 and tyrosine kinases in a megakaryoblast cell line. Diabetes Res Clin Pract. 2005; 70:209-216.
70. Dong F, Zhang X, Yang X, et al. Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice. J Endrocrinol. 2006;188:25-36.
71. Latham JR, Pathirathna S, Jagodic MM, et al. Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice. Diabetes. 2009;58:2656-2665.
72. Zemel MB, Sowers JR, Shehin S, Walsh MF, Levy J. Impaired calcium metabolism associated with hypertension in Zucker obese rats. Metabolism. 1990;39:704-708.
73. Lima-Leopoldo AP, Sugizaki MM, Leopoldo AS, et al. Obesity induces upregulation of genes involved in myocardial Ca2+ handling. Braz J Med Biol Res. 2008;41:615-620.
74. Xue B, Moustaid-Moussa N, Wilkison WO, Zemel MB. The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism. FASEB J. 1998;12:1391-1396.
75. Xue B, Wilkison WO, Mynatt RL, Moustaid N, Goldman M, Zemel MB. The agouti gene product stimulates pancreatic [beta]-cell Ca2+ signaling and insulin release. Physiol Genomics. 1999;1:11-19.
76. Calder PC, Albers R, Antoine JM, et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr. 2000; 101(Suppl):S1-S45.
77. Robinson LE, Buchholz AC, Mazurak VC. Inflammation, obesity, and fatty acid metabolism: Influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome. Appl Physiol Nutr Metab. 2007;32:1998-11024
78. Sohet FM, Neyrinck AM, Pachikian BD, et al. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice. Biochem Pharmacol. 2009;78:1391-1400.
79. DeFuria J, Bennett G, Strissel KJ, et al. Dietary blueberry attenuateswhole-body insulin resistance in high fat-fedmice by reducing adipocytes death and its inflammatory sequelae. J Nutr. 2009;139:1510-1516.
80. Seymour EM, Lewis SK, Urcuyo-Llanes DE, et al. Regular tart cherry intake alters abdominal adiposity, adipose gene transcription, and inflammation in obesity-prone rats fed a high fat diet. J Med Food. 2009;12:935-942.
81. Terra X,Montagut G, Bustos M, et al. Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet. J Nutr Biochem. 2009;20:210-218.
82. Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr. 2008;138:1677-1683.
83. Lee O, Bruce WR, Dong Q, Bruce J, Mehta R, O'Brien PJ. Fructose and carbonyl metabolites as endogenous toxins. Chem Biol Interact. 2009;178:332-339.
84. García OP, Long KZ, Rosado J.L. Impact of micronutrient deficiencies on obesity. Nutr Rev. 2009;67:559-572.
85. Zemel MB, Sun X. 1Alpha, 25-dihydroxyvitamin D3 modulation of adipocytes reactive oxygen species production. Obesity. 2007;15:1944-1953.
86. Abrams SA, GrusakMA, Stuff J, O'Brien KO. Calcium and magnesium balance in 9-14-y-old children. Am J Clin Nutr. 1997;66:1172-1177.
87. Schmitz C, Perraud AL, Johnson CO, et al. Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell. 2003; 114:191-200.
88. Bolland MJ, Barber PA, Doughty RN, et al. Vascular events in healthy older women receiving calcium supplementation: A randomized controlled trial. BMJ. 2008;336:262-266.